Non-small Cell Lung Cancer: Novel Therapeutic Approaches
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 2017
Special Issue Editor
Special Issue Information
Dear Colleagues,
Lung cancer is a major public health problem worldwide, being the leading cause of cancer death due to the long-term ineffectiveness of current therapies and the typically late stage at time of diagnosis. Specifically, the predominant lung cancer subtype, non-small cell lung cancer (NSCLC), accounts for 85% of lung-cancer-associated deaths. Thus, both novel biomarkers and therapeutic approaches for NSCLC are urgently needed.
Potential topics of relevance to this Special Issue include the following:
- novel biomarkers for lung adenocarcinoma (LUAD),
- novel biomarkers for lung squamous cell carcinoma (LUSC),
- experimental therapeutics in NSCLC,
- animal models of NSCLC,
- in vitro models of NSCLC,
- clinical trials in NSCLC.
Dr. Sergio Piñeiro Hermida
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lung cancer
- experimental therapeutics
- novel therapeutic approaches
